Insider Transactions in Q4 2019 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2019
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
6,716
-7.94%
|
$235,060
$35.0 P/Share
|
Dec 05
2019
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,906
-7.51%
|
$90,086
$31.86 P/Share
|
Dec 05
2019
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,860
+13.15%
|
-
|
Nov 25
2019
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
9,969
-5.42%
|
$319,008
$32.51 P/Share
|
Nov 14
2019
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,516
+3.43%
|
$99,352
$22.14 P/Share
|
Nov 05
2019
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
12,475
-5.97%
|
$374,250
$30.01 P/Share
|
Oct 15
2019
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
320,174
-29.18%
|
$8,964,872
$28.02 P/Share
|
Oct 15
2019
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
311,869
+13.22%
|
$1,559,345
$5.01 P/Share
|
Oct 15
2019
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
20,000
-6.49%
|
$560,000
$28.01 P/Share
|